Owlet (OWLT) Q4 2025 earnings review
Record Year Eclipsed by Crushing Tariffs and a Weak Q1 Guide
Owlet finished 2025 with record annual revenue of $105.7M, marking a successful pivot into a comprehensive pediatric health platform powered by the Owlet360 subscription. However, the Q4 print reveals serious cracks in profitability. Gross margin collapsed by nearly 600 basis points year-over-year to 47.6% due to mounting tariff costs, practically wiping out Adjusted EBITDA (down to $0.1M). Even more concerning is the Q1 2026 guidance: revenue is guided to shrink year-over-year, and Adjusted EBITDA is reversing back into negative territory. Management's long-term vision is intact, but the near-term financial reality is messy.
🐂 Bull Case
The Owlet360 subscription service has accelerated rapidly, surpassing 110,000 paying subscribers up from 85,000 in Q3. This diversifies revenue away from pure hardware and creates a high-margin, recurring revenue base.
Despite a soft Q1 forecast, FY26 revenue guidance of $126-$130M implies a healthy 19% to 23% annual growth rate, suggesting underlying consumer demand and international expansion remain robust.
🐻 Bear Case
Management's strategy to move supply chains out of China to Thailand/Vietnam has backfired due to new tariffs. Gross margin decelerated sharply from 53.5% a year ago down to 47.6% this quarter.
Guidance for Q1 2026 revenue is $20-$21M. Compared to Q1 2025 revenue of $21.1M, this implies negative year-over-year growth, breaking a long streak of double-digit top-line expansion.
⚖️ Verdict: ⚪
Neutral. The strategic evolution into a subscription-led medical platform is accelerating beautifully, but the immediate-term financial mechanics are severely pressured by macro supply chain costs and a surprisingly weak Q1 guide.
Key Themes
Owlet360 Adoption is Accelerating
The transition to a Software-as-a-Service model is scaling faster than expected. Paying subscribers for Owlet360 reached 110,000 in Q4, up sequentially from 85,000 in Q3 and 48,000 at the end of Q1. This rapid adoption validates the company's shift toward a pediatric data platform and significantly increases the lifetime value of hardware customers.
Gross Margin Collapse Under Macro Tariff Pressure
The macroeconomic impact of tariffs is reversing previous margin victories. After peaking at 53.7% in Q1 2025, gross margin has steadily compressed, landing at a dismal 47.6% in Q4. Management previously relocated manufacturing from China to Thailand and Vietnam to avoid tariffs, but new 19-20% duties on those specific regions are now heavily penalizing unit economics.
AI Innovation via Dream Sight
Product innovation remains a key growth lever. The rollout of the AI-enabled Dream Sight camera is moving Owlet beyond basic biometric tracking into a sophisticated behavioral monitoring ecosystem. This hardware refresh is critical for driving upgrade cycles and funneling users into the Owlet360 subscription tier.
Reversing Adjusted EBITDA Profitability
After achieving a record $1.6M in Adjusted EBITDA in Q3 2025, Q4 profitability decelerated to just $0.1M. More alarmingly, Q1 2026 guidance explicitly forecasts a return to cash burn, with Adjusted EBITDA guided at $(2.5)M to $(1.5)M. Operating leverage is moving in the wrong direction.
FDA Regulatory Moat Sustains Demand
Owlet continues to benefit from its status as the only FDA-cleared, over-the-counter smart infant monitor. This regulatory moat is effectively defending its market share from cheaper, unverified competitors and is heavily cited by management as the primary driver behind robust registry additions and core Dream Sock volume.
GAAP Net Loss Distorted by Capital Structure
While Adjusted EBITDA shows a breakeven profile, the bottom line looks atrocious to casual observers. FY 2025 Net Loss was $(39.7)M, heavily driven by a $(26.6)M non-cash common stock warrant liability adjustment. Until the capital structure is fully simplified, GAAP earnings will remain volatile and disconnected from operating cash flows.
Other KPIs
Stable compared to $18.4 million in Q4 2024. The decrease was primarily due to lower legal expenses, which were previously elevated due to SPAC-related settlements. However, this was partially offset by increased headcount and stock-based compensation as the company scales its software engineering teams for Owlet360.
Accelerating significantly from $20.2 million at the end of 2024. This was primarily driven by the $32 million equity raise completed in October 2025, providing a vital liquidity bridge to cover the anticipated cash burn in Q1 2026.
Guidance
Reversing trend. At the midpoint ($20.5M), this implies a slight year-over-year contraction compared to the $21.1M delivered in Q1 2025. This completely contradicts the aggressive "35% annual growth" narrative and demands an explanation regarding seasonality, channel inventory destocking, or competitive pressure.
Reversing trend. Management achieved their highly touted "EBITDA profitability" in FY25, only to guide for an immediate return to operating losses in Q1 2026. Lower sequential revenue combined with high fixed costs and persistent tariff pressure are compressing margins.
Accelerating nominal dollars, representing 19% to 23% YoY growth. This suggests management expects massive re-acceleration in the back half of the year to overcome the weak Q1 start. Given the lumpiness of their international distributor rollouts and holiday seasonality, this creates high execution risk for H2 2026.
Stable to slightly improving vs Q4's 47.6%, but down from peak 2025 levels of 53.7%. This explicitly includes the expected impact of ongoing tariff costs, meaning management does not expect near-term relief on the supply chain front.
Accelerating on an annual basis. Implies 50% to 150% growth over the $2.0M generated in FY 2025. Achieving this will require strict operating expense discipline and a heavy reliance on the high-margin software revenue from Owlet360 to offset hardware tariff costs.
Key Questions
The Q1 Revenue Reversal
Q1 2026 revenue guidance implies a year-over-year decline. Is this driven by a tough comparison to last year's severe flu season, a deliberate reduction in channel inventory, or slowing retail demand?
Tariff Mitigation Strategy
Gross margins collapsed to 47.6% in Q4. Since relocating manufacturing to Thailand and Vietnam didn't solve the tariff issue, what is the operational plan to structurally defend unit economics in 2026?
Owlet360 Unit Economics
With subscribers crossing 110,000, can management provide clarity on average revenue per user (ARPU), churn rates, and how much of the $3-$5M FY26 EBITDA guide is dependent on this software segment?
Path to Consistent Profitability
After celebrating a milestone year of profitability, guiding to a $2 million EBITDA loss in Q1 is a tough pill. When does the business achieve consistent, quarter-over-quarter self-sustaining cash flow without relying on equity raises?